Rosemary Watt
Overview
Explore the profile of Rosemary Watt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
377
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Judson M, Mack M, Beaumont J, Watt R, Barnathan E, Victorson D
Am J Respir Crit Care Med
. 2015 Jan;
191(7):786-95.
PMID: 25594886
Rationale: Patient-reported outcome (PRO) measures have been developed to measure symptoms and other aspects of health-related quality of life. Objectives: The Sarcoidosis Assessment Tool (SAT), a sarcoidosis-specific PRO, was administered...
2.
Judson M, Baughman R, Costabel U, Drent M, Gibson K, Raghu G, et al.
Eur Respir J
. 2014 Jul;
44(5):1296-307.
PMID: 25034562
Sarcoidosis is characterised by non-caseating granulomas that secrete pro-inflammatory cytokines, including interleukin (IL)-12, IL-23, and tumour necrosis factor (TNF)-α. Ustekinumab and golimumab are monoclonal antibodies that specifically inhibit IL-12/IL-23 and...
3.
Loza M, Watt R, Baribaud F, Barnathan E, Rennard S
Respir Res
. 2012 Feb;
13:12.
PMID: 22300528
Background: Chronic obstructive pulmonary disease (COPD) is characterized by progressive worsening of airflow limitation associated with abnormally inflamed airways in older smokers. Despite correlative evidence for a role for tumor...
4.
Wenzel S, Barnes P, Bleecker E, Bousquet J, Busse W, Dahlen S, et al.
Am J Respir Crit Care Med
. 2009 Jan;
179(7):549-58.
PMID: 19136369
Rationale: The treatment effect of golimumab, a human monoclonal antibody against tumor necrosis factor (TNF)-alpha, in severe persistent asthma is unknown. Objectives: To assess the safety and efficacy of golimumab...
5.
Rennard S, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, et al.
Am J Respir Crit Care Med
. 2007 Feb;
175(9):926-34.
PMID: 17290043
Rationale: Chronic obstructive pulmonary disease (COPD) is a progressive, smoking-related, inflammatory lung disease in which tumor necrosis factor-alpha is overexpressed and has been suggested to play a pathogenic role. Objectives:...